The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, 310009, China
Location status: Recruiting
Location contact
Jun Jiang
CONTACT
NCT Number: NCT05923489
Comparison of clinical outcomes between routine angiography follow-up and routine clinical follow-up after percutaneous coronary intervention in high-risk patients.
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Hangzhou, Zhejiang, 310009, China
Location status: Recruiting
Jun Jiang
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
A. Left main lesion; B. Bifurcation lesion (true bifurcation); C. Ostial lesion of main vessels (left anterior descending, left circumflex artery, right coronary artery); D. Chronic total occlusion; E. Multivessel revascularization (≥ 2 vessels); F. In-stent restenosis; G. Diffuse long lesion (lesion length ≥ 30 mm or stent length ≥ 38 mm); H. Severe calcified lesion (Significant severe calcification on angiography); I. Bypass graft lesion; J. Diabetes mellitus; K. Chronic kidney disease (defined as an estimated glomerular filtration rate of <30 ml per minute per 1.73 m2 of body-surface area or the receipt of dialysis); L. Myocardial infarction;
Exclusion criteria
Patients in the RAF group will have routine angiography follow-up at 12 months after revascularization.
Patients in the RCF group will have routine clinical follow-up at 12 months after revascularization, and the physician will decide whether further invasive testing is needed.
Time frame: 24 months
The rate of a composite endpoint of all-cause death, myocardial infarction, or hospitalization for unstable angina
Time frame: 60 months
The rate of a composite endpoint of all-cause death, myocardial infarction, or hospitalization for unstable angina
Time frame: 24 and 60 months
The rate of all-cause death
Time frame: 24 and 60 months
The rate of myocardial infarction
Time frame: 24 and 60 months
The rate of hospitalization for unstable angina
Time frame: 24 and 60 months
The rate of hospitalization for cardiac death
Time frame: 24 and 60 months
The rate of invasive angiography during follow-up
Time frame: 24 and 60 months
The rate of any revascularization during follow-up (ischemia-driven vs. all-cause)
Time frame: 24 and 60 months
The rate of revascularization of any target vessel/lesion
Time frame: 24 and 60 months
The rate of revascularization of any non-target vessel/lesion
Time frame: 24 and 60 months
Contact information is provided by the study sponsor or research team.
Jinlong Zhang, MD, PhD
CONTACT
Jun Jiang, MD, PhD
CONTACT
Second Affiliated Hospital, School of Medicine, Zhejiang University
Other
Routine Angiography Follow-Up After Percutaneous Coronary Intervention in High-Risk Patients (The REVISE Trial)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07720349
Arterial Occlusive Diseases, Arteriosclerosis
Arendal, Norway
View Trial DetailsNCT02038127
Arterial Occlusive Diseases, Arteriosclerosis
Chuncheon, Gangwon-do, South Korea
View Trial DetailsNCT07190690
Arterial Occlusive Diseases, Arteriosclerosis
Alicante, Spain
View Trial DetailsNCT05611307
ASCVD, Arterial Occlusive Diseases
Indianapolis, Indiana, United States
View Trial Details